Avantax Advisory Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.69M Buy
9,426
+436
+5% +$75.7K 0.01% 883
2025
Q1
$1.52M Buy
8,990
+535
+6% +$87.9K 0.01% 887
2024
Q4
$1.28M Buy
8,455
+4,164
+97% +$648K 0.01% 933
2024
Q3
$666K Sell
4,291
-152
-3% -$22.7K ﹤0.01% 1239
2024
Q2
$608K Buy
4,443
+1,705
+62% +$233K ﹤0.01% 1243
2024
Q1
$364K Buy
2,738
+571
+26% +$74.1K ﹤0.01% 1196
2023
Q4
$299K Buy
2,167
+38
+2% +$5K ﹤0.01% 1235
2023
Q3
$259K Sell
2,129
-747
-26% -$99.5K ﹤0.01% 1279
2023
Q2
$404K Buy
2,876
+42
+1% +$5.79K ﹤0.01% 1033
2023
Q1
$401K Buy
2,834
+10
+0.4% +$1.43K ﹤0.01% 1007
2022
Q4
$442K Sell
2,824
-755
-21% -$108K 0.01% 922
2022
Q3
$439K Buy
3,579
+1,261
+54% +$166K 0.01% 829
2022
Q2
$308K Sell
2,318
-571
-20% -$77.8K ﹤0.01% 994
2022
Q1
$396K Sell
2,889
-451
-14% -$62.9K 0.01% 879
2021
Q4
$578K Sell
3,340
-577
-15% -$87.8K 0.01% 712
2021
Q3
$565K Sell
3,917
-30
-0.8% -$4.39K 0.01% 679
2021
Q2
$519K Buy
3,947
+693
+21% +$90.7K 0.01% 700
2021
Q1
$417K Buy
3,254
+8
+0.2% +$986 0.01% 679
2020
Q4
$387K Buy
3,246
+251
+8% +$30.6K 0.01% 636
2020
Q3
$342K Buy
2,995
+719
+32% +$84.9K 0.01% 963
2020
Q2
$258K Buy
+2,276
New +$241K 0.01% 699

Other funds holding DGX

Avantax Advisory Services's DGX Position: Q2 2025 in Review

Avantax Advisory Services increased its Quest Diagnostics (DGX) stake by 4.8% in Q2 2025, buying an estimated $75.7K and bringing the position to 9,426 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #883.

Avantax Advisory Services first reported a position in DGX in Q2 2020 and has held it in 21 quarters since. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Avantax Advisory Services held 9,426 shares of Quest Diagnostics worth $1.69M as of Q2 2025.
  • Avantax Advisory Services bought 436 Quest Diagnostics shares in Q2 2025, an estimated $75.7K.
  • Quest Diagnostics made up 0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #883 holding.
  • Avantax Advisory Services first reported a position in Quest Diagnostics in Q2 2020 and has held it in 21 quarters since.
  • 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.